Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Mouse Models of Yersiniosis.

Hooker-Romero D, Schwiesow L, Wei Y, Auerbuch V.

Methods Mol Biol. 2019;2010:41-53. doi: 10.1007/978-1-4939-9541-7_4.

PMID:
31177430
2.

Editorial: The Pathogenic Yersiniae-Advances in the Understanding of Physiology and Virulence, Second Edition.

Francis MS, Auerbuch V.

Front Cell Infect Microbiol. 2019 Apr 18;9:119. doi: 10.3389/fcimb.2019.00119. eCollection 2019. No abstract available.

3.

Complete Genome Assembly of Yersinia pseudotuberculosis IP2666pIB1.

Zoubeidi A, Schwiesow L, Auerbuch V, Lam HN.

Microbiol Resour Announc. 2019 Feb 14;8(7). pii: e01592-18. doi: 10.1128/MRA.01592-18. eCollection 2019 Feb.

4.

An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic Yersinia.

Morgan JM, Lam HN, Delgado J, Luu J, Mohammadi S, Isberg RR, Wang H, Auerbuch V.

Front Cell Infect Microbiol. 2018 Nov 22;8:404. doi: 10.3389/fcimb.2018.00404. eCollection 2018.

5.

Control of hmu Heme Uptake Genes in Yersinia pseudotuberculosis in Response to Iron Sources.

Schwiesow L, Mettert E, Wei Y, Miller HK, Herrera NG, Balderas D, Kiley PJ, Auerbuch V.

Front Cell Infect Microbiol. 2018 Feb 22;8:47. doi: 10.3389/fcimb.2018.00047. eCollection 2018.

6.

Investigation of the Physical and Bioactive Properties of Bromo- and Iodo-Containing Sponge-Derived Compounds Possessing an Oxyphenylethanamine Core.

McCauley EP, Lam H, Lorig-Roach N, Luu J, Lloyd C, Tenney K, Pietraszkiewicz H, Diaz C, Valeriote FA, Auerbuch V, Crews P.

J Nat Prod. 2017 Dec 22;80(12):3255-3266. doi: 10.1021/acs.jnatprod.7b00694. Epub 2017 Nov 16.

PMID:
29144750
7.

Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.

Lam H, Schwochert J, Lao Y, Lau T, Lloyd C, Luu J, Kooner O, Morgan J, Lokey S, Auerbuch V.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e00060-17. doi: 10.1128/AAC.00060-17. Print 2017 Sep.

8.

Piericidin A1 Blocks Yersinia Ysc Type III Secretion System Needle Assembly.

Morgan JM, Duncan MC, Johnson KS, Diepold A, Lam H, Dupzyk AJ, Martin LR, Wong WR, Armitage JP, Linington RG, Auerbuch V.

mSphere. 2017 Feb 15;2(1). pii: e00030-17. doi: 10.1128/mSphere.00030-17. eCollection 2017 Jan-Feb.

9.

Bacterial internalization is required to trigger NIK-dependent NF-κB activation in response to the bacterial type three secretion system.

Duncan MC, Herrera NG, Johnson KS, Engel JN, Auerbuch V.

PLoS One. 2017 Feb 6;12(2):e0171406. doi: 10.1371/journal.pone.0171406. eCollection 2017.

10.

The Type III Secretion System Cleans up Its Act(in).

Auerbuch V.

Cell Host Microbe. 2016 Sep 14;20(3):275-276. doi: 10.1016/j.chom.2016.08.012.

11.

Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System.

Miller HK, Schwiesow L, Au-Yeung W, Auerbuch V.

Front Cell Infect Microbiol. 2016 Jun 24;6:69. doi: 10.3389/fcimb.2016.00069. eCollection 2016.

12.

Erratum for Duncan et al., An NF-κB-Based High-Throughput Screen Identifies Piericidins as Inhibitors of the Yersinia pseudotuberculosis Type III Secretion System.

Duncan MC, Wong WR, Dupzyk AJ, Bray WM, Linington RG, Auerbuch V.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4427. doi: 10.1128/AAC.00973-16. Print 2016 Jul. No abstract available.

13.

Yersinia Type III Secretion System Master Regulator LcrF.

Schwiesow L, Lam H, Dersch P, Auerbuch V.

J Bacteriol. 2015 Dec 7;198(4):604-14. doi: 10.1128/JB.00686-15. Review.

14.

Bacterial iron-sulfur cluster sensors in mammalian pathogens.

Miller HK, Auerbuch V.

Metallomics. 2015 Jun;7(6):943-56. doi: 10.1039/c5mt00012b. Review.

15.

Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.

Adams W, Morgan J, Kwuan L, Auerbuch V.

Mol Microbiol. 2015 May;96(4):764-78. doi: 10.1111/mmi.12970. Epub 2015 Mar 16.

16.

IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.

Miller HK, Kwuan L, Schwiesow L, Bernick DL, Mettert E, Ramirez HA, Ragle JM, Chan PP, Kiley PJ, Lowe TM, Auerbuch V.

PLoS Pathog. 2014 Jun 12;10(6):e1004194. doi: 10.1371/journal.ppat.1004194. eCollection 2014 Jun.

17.

An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.

Duncan MC, Wong WR, Dupzyk AJ, Bray WM, Linington RG, Auerbuch V.

Antimicrob Agents Chemother. 2014;58(2):1118-26. doi: 10.1128/AAC.02025-13. Epub 2013 Dec 2. Erratum in: Antimicrob Agents Chemother. 2016 Jul;60(7):4427.

18.

Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response.

Kwuan L, Adams W, Auerbuch V.

Infect Immun. 2013 Mar;81(3):905-14. doi: 10.1128/IAI.01014-12. Epub 2013 Jan 7.

19.

Chemical inhibitors of the type three secretion system: disarming bacterial pathogens.

Duncan MC, Linington RG, Auerbuch V.

Antimicrob Agents Chemother. 2012 Nov;56(11):5433-41. doi: 10.1128/AAC.00975-12. Epub 2012 Jul 30. Review.

20.

Innate immune recognition of Yersinia pseudotuberculosis type III secretion.

Auerbuch V, Golenbock DT, Isberg RR.

PLoS Pathog. 2009 Dec;5(12):e1000686. doi: 10.1371/journal.ppat.1000686. Epub 2009 Dec 4.

21.
22.

Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system.

Herskovits AA, Auerbuch V, Portnoy DA.

PLoS Pathog. 2007 Mar;3(3):e51.

23.

Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.

Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA.

J Exp Med. 2004 Aug 16;200(4):527-33. Epub 2004 Aug 9.

24.
25.

The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity.

Portnoy DA, Auerbuch V, Glomski IJ.

J Cell Biol. 2002 Aug 5;158(3):409-14. Epub 2002 Aug 5. Review.

26.

Microbial pathogenesis and the eukaryotic cytoskeleton at the American Society for Cell Biology annual meeting.

Auerbuch V, Portnoy DA.

Cell Microbiol. 2002 Mar;4(3):187-90. No abstract available.

PMID:
11906455
27.

Pivotal role of VASP in Arp2/3 complex-mediated actin nucleation, actin branch-formation, and Listeria monocytogenes motility.

Skoble J, Auerbuch V, Goley ED, Welch MD, Portnoy DA.

J Cell Biol. 2001 Oct 1;155(1):89-100.

29.

Stability of the Listeria monocytogenes ActA protein in mammalian cells is regulated by the N-end rule pathway.

Moors MA, Auerbuch V, Portnoy DA.

Cell Microbiol. 1999 Nov;1(3):249-57.

PMID:
11207557
30.

Analysis of genes encoding an alternative nitrogenase in the archaeon Methanosarcina barkeri 227.

Chien YT, Auerbuch V, Brabban AD, Zinder SH.

J Bacteriol. 2000 Jun;182(11):3247-53.

Supplemental Content

Loading ...
Support Center